Taking Science to Impact
Health Impacts of the New WHO Air Quality Guidelines in European Cities
In a recent The Lancet Planet feature, researchers from ISGLOBAL, Swiss TPH and other organisations found that a large number of premature deaths in Europe could be prevented annually if air pollution levels decreased to meet the World Health Organization (WHO) Air Quality Guidelines.
Read full article
Improving Health Insurance Coverage in LMICs
The Geneva Health Forum and the Swiss Tropical and Public Health Institute are pleased to invite you to the GHF Virtual Roundtable, "Improving Health Insurance Coverage in LMICs" taking place on Monday, 22 November 2021, 12:00-14:00 CET, with simultaneous translation English <-> French.
More information and registration
COVID-19 Vaccination
As the official COVID-19 vaccination centre of the canton of Basel-Stadt, we offer vaccination with Moderna (Spikevax®) and Janssen (Johnson & Johnson).
Geneva Health Forum 2022: Call for Contributions
Within the overall thematic “Covid-19 Pandemic and Environmental Emergency : Reinventing Global Health in times of Global Changes!” the GHF is launching a call for contributions for the next edition of its conference taking place from 3rd to 5th May 2022.
More informationNews
All News
16.11.2021
Clinical Trials Completed for a New Drug to Treat Parasitic Worm Infections in Infants
The Pediatric Praziquantel Consortium completed its pivotal clinical Phase III trial of arpraziquantel – a potential new treatment option for the estimated 50 million... More...
09.11.2021
A Decline in Air Pollution Levels in Europe Still Fall Short of WHO Guidelines, According to New Study
A new study by Swiss TPH used robust spatio-temporal methodology to show the reduction in air pollution across Europe from 2006-2019 and found that while exposure rates have... More...
20.10.2021
TB-PRACTECAL: Clinical Trial Yields Promising Results for Drug-Resistant Tuberculosis Treatment
TB-PRACTECAL, a clinical trial led by Médecins Sans Frontières with partners including Swiss TPH, has found that a new all-oral treatment regimen for rifampicin-resistant... More...